ROLE OF RYANODINE RECEPTORS

被引:237
作者
OGAWA, Y
机构
[1] Department of Pharmacology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo
关键词
CA RELEASE CHANNEL PROTEIN; CA2+-INDUCED CA RELEASE; ACTION POTENTIAL-INDUCED CA RELEASE; RYANODINE RECEPTOR ISOFORMS; MALIGNANT HYPERTHERMIA;
D O I
10.3109/10409239409083482
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent findings on the ryanodine receptor of vertebrates, a Ca-release channel protein for the caffeine- and ryanodine-sensitive Ca pools, are reviewed in this article. Three distinct genes, i.e., ryr1, ryr2, and ryr3, express different isoforms in specific locations: Ryr1 in skeletal muscle and Purkinje cells of cerebellum; Ryr2 in cardiac muscle and brain, especially cerebellum; Ryr3 in skeletal muscle of nonmammalian vertebrates, the corpus striatum, and limbic cortex of brain, smooth muscles, and the other cells in vertebrates. While only one isoform (Ryr1) is expressed in mammalian skeletal muscles, two isoforms (alpha- and beta-isoforms expressed by ryr1 and ryr3, respectively) are found in nonmammalian vertebrate skeletal muscles. Although the coexistence of two isoforms may merely be related to differentiation and specialization, the biological significance remains to be clarified. Ryanodine receptors in vertebrate skeletal muscles are believed to mediate two different modes of Ca release: Ca2+-induced Ca release and action potential-induced Ca release. All results obtained so far with any isoform of ryanodine receptor are related to Ca2+-induced Ca release and show very similar characteristics. Ca2+-induced Ca release, however, cannot be the underlying mechanism of Ca release on skeletal muscle activation. Susceptibility of the ryanodine receptor's ryanodine-binding activity to modification by physical factors, such as osmolality of the medium, might be related to action potential-induced Ca release. A hypothesis of molecular interaction in view of the plunger model of action potential-induced Ca release is discussed, suggesting that the model could be compatible with Ryr1 and Ryr3, but incompatible with Ryr2. The functional relevance of ryanodine receptor isoforms, especially Ryr3, in brain also remains to be clarified. Among ryr1 gene-related diseases, malignant hyperthermia was the first to be identified; however, there is still the possibility of involvement of the other genes. Central core disease has been added to the list recently. A molecular approach for the diagnosis and treatment of diseases is now in progress.
引用
收藏
页码:229 / 274
页数:46
相关论文
共 325 条
  • [51] Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0
  • [52] EXCITATION-CONTRACTION COUPLING AND THE MECHANISM OF MUSCLE-CONTRACTION
    EBASHI, S
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1991, 53 : 1 - 16
  • [53] EBASHI S, 1988, HDB EXPT PHARM, V83, P31
  • [54] INOSITOL 1,4,5-TRISPHOSPHATE ACTIVATES A CHANNEL FROM SMOOTH-MUSCLE SARCOPLASMIC-RETICULUM
    EHRLICH, BE
    WATRAS, J
    [J]. NATURE, 1988, 336 (6199) : 583 - 586
  • [55] ACTIVATION OF THE CA-2+ RELEASE CHANNEL OF SKELETAL-MUSCLE SARCOPLASMIC-RETICULUM BY PALMITOYL CARNITINE
    ELHAYEK, R
    VALDIVIA, C
    VALDIVIA, HH
    HOGAN, K
    CORONADO, R
    [J]. BIOPHYSICAL JOURNAL, 1993, 65 (02) : 779 - 789
  • [56] IDENTIFICATION AND LOCALIZATION OF RYANODINE BINDING-PROTEINS IN THE AVIAN CENTRAL-NERVOUS-SYSTEM
    ELLISMAN, MH
    DEERINCK, TJ
    OUYANG, Y
    BECK, CF
    TANKSLEY, SJ
    WALTON, PD
    AIREY, JA
    SUTKO, JL
    [J]. NEURON, 1990, 5 (02) : 135 - 146
  • [57] ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181
  • [58] MECHANISM OF ACTION OF CAFFEINE ON SARCOPLASMIC-RETICULUM OF SKELETAL-MUSCLE
    ENDO, M
    [J]. PROCEEDINGS OF THE JAPAN ACADEMY, 1975, 51 (06): : 479 - 484
  • [59] CALCIUM INDUCED RELEASE OF CALCIUM FROM SARCOPLASMIC RETICULUM OF SKINNED SKELETAL MUSCLE FIBRES
    ENDO, M
    TANAKA, M
    OGAWA, Y
    [J]. NATURE, 1970, 228 (5266) : 34 - &
  • [60] CHANGES IN THE CA-INDUCED CA RELEASE MECHANISM IN THE SARCOPLASMIC-RETICULUM OF THE MUSCLE FROM A PATIENT WITH MALIGNANT HYPERTHERMIA
    ENDO, M
    YAGI, S
    ISHIZUKA, T
    HORIUTI, K
    KOGA, Y
    AMAHA, K
    [J]. BIOMEDICAL RESEARCH-TOKYO, 1983, 4 (01): : 83 - 92